More recent studies suggest that IL-1α can also be activated by sublethal damage, such as oxidative stress and DNA injury [16], and plays roles in both tumor progression and anti-tumor immunity within the tumor microenvironment [17]. The gene discussed is IL1A; the disease is neoplasm.